SCHEMBL879303

SCHEMBL879303

CC(C)C(=O)c1cc(I)cc(I)c1I

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.39
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35
FFAR1 O14842 1/20 0.35
TPMT P51580 1/20 0.34
KDM4E B2RXH2 3/20 0.33
POLB P06746 2/20 0.33
NLRP3 Q96P20 1/20 0.33
DBH P09172 1/20 0.33
GAA P10253 1/20 0.33
RECQL P46063 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL879358 0.79 TTR (0.46) TTRHDAC3HDAC4HDAC1HDAC7
2,3,5-Triiodobenzoic Acid SCHEMBL39041 0.74 TPMT (0.50) TTRHDAC3HDAC4HDAC1HDAC7
SCHEMBL7792795 0.73 HDAC3 (0.33) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL12966232 0.72 HDAC3 (0.41) TTRHDAC3HDAC4HDAC1HDAC7
SCHEMBL29595299 0.72 HDAC3 (0.41) TTRHDAC3HDAC4HDAC1HDAC7
2,3,5-Triiodobenzoic Acid SCHEMBL23524593 0.72 TPMT (0.48) TTRHDAC3HDAC4HDAC1HDAC7
2,3,5-Triiodobenzoic Acid SCHEMBL6397062 0.72 TPMT (0.48) TTRHDAC3HDAC4HDAC1HDAC7
SCHEMBL879357 0.72 TTR (0.39) TTRHDAC3HDAC4HDAC1HDAC7
SCHEMBL29367522 0.72 TTR (0.39) TTRHDAC3HDAC4HDAC1HDAC7
2,3,5-Triiodobenzoic Acid SCHEMBL2960018 0.72 TPMT (0.48) TTRHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1815871-B1 Radiographic contrasting agents and radio-opaque polymeric materials for medical devices CORDIS CORP (US) 2012-03-28 EP disclosed
US-7771705-B2 Radiographic contrasting agents and radio-opaque polymeric materials for medical devices CORDIS CORPORATION (US) 2010-08-10 US disclosed
US-20090209745-A1 RADIOGRAPHIC CONTRASTING AGENTS AND RADIO-OPAQUE POLYMERIC MATERIALS FOR MEDICAL DEVICES CORDIS US CORP 2009-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209745-A1 RADIOGRAPHIC CONTRASTING AGENTS AND RADIO-OPAQUE POLYMERIC MATERIALS FOR MEDICAL DEVICES MYADM, PBRM1, RXFP3 TTR 2900/4885HDAC3 1323/4885HDAC4 1984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.